Welcome to the VWD Symposium Talk Series! Join Dr. Jerry Teitel as he delves into the crucial topic of confronting inequities in healthcare, specifically focusing on Von Willebrand Disease (VWD) and its comparison to Hemophilia. In this insightful interview, Dr. Teitel discusses the significant challenges faced in VWD care today, explores how healthcare systems can address these inequalities, and shares transformative key takeaways that could enhance the understanding and treatment of VWD.

Timestamps:
0:00 - What are the most significant challenges in VWD care today, especially in comparison to hemophilia?
1:40 - How can healthcare systems address the inequities in treatment and recognition between VWD and hemophilia?
4:00 - As a chair of VWD state of care symposium, could you share your thoughts on it and its importance to the community?
5:22- Could you share 2-3 key takeaways from your session that could transform the understanding or treatment of VWD?

About Von Willebrand Disease and VWD Symposium:
Von Willebrand Disease (VWD) is one of the most prevalent inherited bleeding disorders globally, impacting thousands of Canadians. The Von Willebrand Disease State of Care Symposium is an endeavor to give shape to future standard of care for VWD patients that takes into consideration their unmet needs, providing them an equal opportunity to engage fully with all life experiences in Canada.
The faculty will address practical issues such as diagnostic challenges, treatment gaps, role of prophylaxis and long-term management strategies along with aspects of quality-of-life of VWD patients.

#vonwillebranddisease #VWD #hemophilia #heavymenstrualbleeding #bleedingdisorders

свернуть